Bleecker, E R <br/><br/>
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma.  [electronic resource] 

 -  The Journal of allergy and clinical immunology  Jun 2000 
 - 1123-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-6749 
<br/><br/><label>Standard No.: </label>10.1067/mai.2000.106043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Inhalation<br/>Administration, Oral<br/>Adult<br/>Aged<br/>Androstadienes--administration & dosage<br/>Anti-Asthmatic Agents--administration & dosage<br/>Asthma--drug therapy<br/>Child<br/>Dose-Response Relationship, Drug<br/>Female<br/>Fluticasone<br/>Forced Expiratory Volume<br/>Humans<br/>Indoles<br/>Male<br/>Middle Aged<br/>Phenylcarbamates<br/>Sulfonamides<br/>Therapeutic Equivalency<br/>Tosyl Compounds--administration & dosage